These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 21801836

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of CD200 and CD200R1 expression within tissue grafts on increased graft survival in allogeneic recipients.
    Yu K, Chen Z, Gorczynski R.
    Immunol Lett; 2013 Jan; 149(1-2):1-8. PubMed ID: 23178470
    [Abstract] [Full Text] [Related]

  • 3. CCR4 dependent migration of Foxp3+ Treg cells to skin grafts and draining lymph nodes is implicated in enhanced graft survival in CD200tg recipients.
    Yu K, Chen Z, Khatri I, Gorczynski RM.
    Immunol Lett; 2011 Dec 30; 141(1):116-22. PubMed ID: 21945175
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Reduction of Foxp3-expressing regulatory T cell infiltrates during the progression of renal allograft rejection in a mouse model.
    Wang S, Jiang J, Guan Q, Lan Z, Wang H, Nguan CY, Jevnikar AM, Du C.
    Transpl Immunol; 2008 May 30; 19(2):93-102. PubMed ID: 18503884
    [Abstract] [Full Text] [Related]

  • 8. Expression of a CD200 transgene is necessary for induction but not maintenance of tolerance to cardiac and skin allografts.
    Gorczynski RM, Chen Z, He W, Khatri I, Sun Y, Yu K, Boudakov I.
    J Immunol; 2009 Aug 01; 183(3):1560-8. PubMed ID: 19592654
    [Abstract] [Full Text] [Related]

  • 9. Thymocyte/splenocyte-derived CD4+CD25+Treg stimulated by anti-CD200R2 derived dendritic cells suppress mixed leukocyte cultures and skin graft rejection.
    Gorczynski RM.
    Transplantation; 2006 Apr 15; 81(7):1027-34. PubMed ID: 16612280
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
    He F, Chen Z, Xu S, Cai M, Wu M, Li H, Chen X.
    Surgery; 2009 Jun 15; 145(6):663-74. PubMed ID: 19486771
    [Abstract] [Full Text] [Related]

  • 13. A tolerogenic semimature dendritic cells induce effector T-cell hyporesponsiveness by activation of antigen-specific CD4+CD25+ T regulatory cells that promotes skin allograft survival in mice.
    Fu BM, He XS, Yu S, Hu AB, Zhang J, Ma Y, Tam NL, Huang JF.
    Cell Immunol; 2010 Jun 15; 261(1):69-76. PubMed ID: 20038461
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Costimulation blockade-induced cardiac allograft tolerance: inhibition of T cell expansion and accumulation of intragraft cD4(+)Foxp3(+) T cells.
    Oderup C, Malm H, Ekberg H, Qi Z, Veress B, Ivars F, Corbascio M.
    Transplantation; 2006 Dec 15; 82(11):1493-500. PubMed ID: 17164722
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The role of Foxp3+ regulatory T cells in liver transplant tolerance.
    Li W, Carper K, Zheng XX, Kuhr CS, Reyes JD, Liang Y, Perkins DL, Thomson AW, Perkins JD.
    Transplant Proc; 2006 Dec 15; 38(10):3205-6. PubMed ID: 17175223
    [Abstract] [Full Text] [Related]

  • 19. Combined therapy of CD4(+)CD25(+) regulatory T cells with low-dose sirolimus, but not calcineurin inhibitors, preserves suppressive function of regulatory T cells and prolongs allograft survival in mice.
    Ma A, Qi S, Wang Z, Massicotte E, Dupuis M, Daloze P, Chen H.
    Int Immunopharmacol; 2009 May 15; 9(5):553-63. PubMed ID: 19539558
    [Abstract] [Full Text] [Related]

  • 20. Soluble donor-like MHC class I proteins induce CD4(+)CD25(+)CD8(-)FoxP3(+) cells with potential to ameliorate graft chronic injury.
    Andakyan A, Burruss S, Hong LS, Shen XD, Romanov S, Gao F, Feldman DM, Fishbein MC, Semiletova NV.
    Transpl Immunol; 2011 May 15; 24(4):203-9. PubMed ID: 21251981
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.